Biotechnology

New UKIPO “IP Access” Fund. Up to £5,000 Intellectual Property Grant Available for SMEs

As part of the UK Government’s strategy to rebound the economy through the success of knowledge-led high skill businesses, the UK Intellectual Property Office (UKIPO) has launched a new IP Access fund as an extension of the existing IP Audit Plus programme. This new fund, which offers grants of up...

Read more

Patenting Biological Simulations in Drug Discovery

  Our article ‘Patenting Biological Simulations in Drug Discovery’ has been published in Drug Discovery Today, by Elsevier. It examines the challenges faced when pursuing patent protection for biological simulations, particularly in view of the guidance provided by the European Patent Office in G1/19. Article Highlights: Biological simulations typically require...

Read more

Is Dasatinib Dead? – An Incredible Change to the Plausibility Threshold

  It is just over four years since Board 3.3.01 of the EPO Boards of Appeal delivered its much-anticipated decision in the Dasatinib case (T 488/16). Having been closely involved in that case on behalf of one of the opponents, it was obvious to me that the decision represented a...

Read more

Neurodegenerative Disease: Is Your IP Strategy Setting You Up for Success?

With an ever-aging population, one of the biggest challenges facing the modern world is the rising prevalence of neurodegenerative disease. Neurodegenerative disease is a collective term for a number of diseases characterised by the loss of structure, or function, of neurons; the building blocks of the nervous system. Examples of...

Read more

Wisdom of the crowd: how to make sure IP doesn’t derail your crowdfunding efforts

Startups raising hundreds of thousands – even millions – of pounds via Kickstarter may be rarer than it once was, but crowdfunding remains a popular method of fundraising. There are a myriad of options, whether you go down the equity crowdfunding route offered by the likes of Seedrs, CrowdCube, and...

Read more